Johanna Elin Gehin

10PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityDisease surveillanceClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 19, 2026
Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomised controlled trial.

Teresa Holly, Marthe Kirkesaether Brun, Kristin Kaasen Jørgensen

|Feb 02, 2026
The Effect of Certolizumab Pegol Dose and Dose Changes on Plasma Trough Levels: Data From a Randomized Phase III Trial.

Johanna E Gehin, Rolf A Klaasen, Eirik K Kristianslund

|Nov 13, 2024
Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial.

Johanna Elin Gehin, Rolf Anton Klaasen, Eirik Klami Kristianslund

|Feb 27, 2023
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases.

Marthe Kirkesaether Brun, Kristin Hammersbøen Bjørlykke, Marte K Viken

|Oct 31, 2022
Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine.

Johanna Elin Gehin, Guro Løvik Goll, Marthe Kirkesæther Brun

|Aug 18, 2022
Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider.

Charlotte Krieckaert, Borja Hernández-Breijo, Johanna Elin Gehin

Pageof 2

Frequent Collaborators

5 joint publications

Silje Watterdal Syversen

3 joint publications

Meghna Jani

3 joint publications

Guro Løvik Goll

2 joint publications

Rolf A Klaasen